Contact
Private Area
Español
BME MTF Equity Other Segments
Trading sesion
07/11/2019 Close
0.0210
Last price
0.45 mill. €
Capitalisation
-46.15
Dif.(%)
-44.00
% Year 2019
Santiago de Torres
Chairman
"We are a company that combines innovation with diagnosis and treatment".
Excluded 08/11/2019
Last Trade
Date
07/11/2019
Hour
Close
Last
Ref.
0.0390
Volume (Shares)
6,403,576
Turnover (€x1000)
101.28
ATRYS D2019-OCTUBRE
ATR.D
ES0605148917
A-84942150
21.555.051
-
Continuo
GVC GAESCO VALORES, S.V., S.A.
KPMG AUDITORES, S.L
PRíNCIPE DE VERGARA 132, 28002 MADRID
relacioninversores@atryshealth.com
Capital Admitted (thousands of euros)
Shares (x 1,000)
Period Close Price (euros)
Period Last Price (euros)
Period High Price (euros)
Period Low Price (euros)
Capitalisation (thousands of euros)
Volume (thousands of shares)
Turnover (thousands of euros)
"ATRYS Health specializes in innovative medical diagnostic imaging.and personalized cancer diagnosis and treatments in advanced single-dose radiation therapy company. Our commitment to R & D puts us at the forefront of individualized medicine ."
Atrys Health (BME:ATRY), founded in 2015, is a global medical services provider with more than 2,200 professionals and presence in 8 countries. A pioneer in the fields of telemedicine and state-of-the-art radiotherapy, it has a solid track record of organic and inorganic growth with the integration of 14 companies since 2018.
Atrys focuses its activity around three business units: prevention, diagnosis and oncology. Through these three areas, provides a 360º service, covering everything from prevention to cancer treatment, including precision diagnosis and the use of telemedicine. Thus, the company performs diagnostic tests, analyses using telemedicine tests on radiology, cardiology, ophthalmology and dermatology and provides medical oncology services carrying out chemotherapy, immunotherapy and advanced radiotherapy treatments.
Interview with Santiago de TorresChairman of Atrys Health
Atrys HealthDiscovery MeetingForo Medcap 2021
To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.
The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties for a fee, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.
Follow us in
What is BME Growth
Companies
Market
Indices
News and Publications
Investors
Listed Companies
Copyright © BME 2025. All rights reserved.